Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Stock Information | RedChip

Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Listen to this Section


$5.58
N/A ( 0% ) 41.9K

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Market Data


Open


$5.58

Previous close


$5.58

Volume


41.9K

Market cap


$152.15M

Day range


$5.55 - $5.69

52 week range


$5.26 - $11.92

Insider Ownership Transactions

Total Amount Purchased: -200,673.00 | $ -1,119,755.34

Date Type Amount Purchased Purchaser
2023-08-18 Sale -673.00 RALLIS CHRIS A
2023-08-07 Sale -200000.00 Haigh Adrian

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Mar 27, 2024
4 Insider transactions 1 Mar 27, 2024
4 Insider transactions 1 Mar 25, 2024
8-k 8K-related 15 Mar 25, 2024
8-k 8K-related 18 Mar 21, 2024
8-k/a 8K-related 16 Mar 06, 2024
8-k 8K-related 16 Feb 29, 2024
8-k 8K-related 16 Feb 02, 2024
4 Insider transactions 1 Jan 05, 2024
4 Insider transactions 1 Dec 29, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.